Sort by
Refine Your Search
-
VwGr. B1 lit. b (postdoc) Limited until: permanent Reference no.: 4874 The position is part of the Solar System Evolution group led by Ass.-Prof. Kristina Kislyakova. The main research direction
-
development. Incorporating recent research findings into our teaching is of paramount importance for us. Subsequently, our expertise is requested for the development and revision of state-of-the-art curricula
-
Invertebrate Evolution with a focus on either comparative morphology, EvoDevo, or phylogenomics. We are a dynamic, international group situated in the recently built University of Vienna Biology Building (UBB
-
, the organization and execution of a lecture series in the summer semester of 2026, as well as the planning of workshops and public events, and the development of participatory structures for local and regional
-
Austrian and European labor and social law. Its wide-ranging activities in research and teaching, as well as access to a well-equipped library, enable excellent academic training and personal development
-
framework to examine the origins, development, and consequences of patient engagement with antenatal drug use, iatrogenic disability, and reproductive health from the 1960s until today. The PI of the project
-
framework to examine the origins, development, and consequences of patient engagement with antenatal drug use, iatrogenic disability, and reproductive health from the 1960s until today. The PI of the project
-
, development, and consequences of patient engagement with antenatal drug use, iatrogenic disability, and reproductive health from the 1960s until today. The PI of the project is Prof. Birgit Nemec, chair
-
(400–700 MHz, solution- and solid-state NMR, EPR, Prodigy and He-Cryo units), ensuring optimal performance and reliability. Method development: Develop and optimize pulse programs and parameter sets
-
conjugation, lipid coupling, and the development of tailored molecular probes. You will work extensively with analytical techniques such as NMR and MS and contribute to our fragment-based drug design efforts